What is Bexorg?
Bexorg is a privately held company at the forefront of transforming central nervous system (CNS) drug discovery and development. Leveraging the world's first integrated AI and whole-human brain platform, Bexorg's BrainEx platform, combined with advanced AI models, creates a highly clinically predictive system in neuroscience. Founded by Dr. Zvonimir Vrselja and Dr. Nenad Sestan at Yale University, the company operates under stringent legal and bioethical standards, overseen by an independent board of experts. This strategic investment underscores the significant potential recognized in Bexorg's innovative approach to neuroscience.
How much funding has Bexorg raised?
Bexorg has raised a total of $23M across 1 funding round:
Series A
$23M
Series A (2025): $23M with participation from Starbloom Capital, Little Engine Ventures, Connecticut Innovations, and Amplify Partners
Key Investors in Bexorg
Starbloom Capital
Starbloom Capital invests in breakthrough innovations in neuroAI, longevity, and deep tech, partnering with visionary founders pushing the frontiers of science and technology.
Connecticut Innovations
Connecticut Innovations is the state's strategic venture capital arm, providing financing and guidance to innovative companies in sectors like AI, climate tech, and biosciences.
Amplify Partners
Amplify Partners focuses on early-stage companies in machine intelligence and computer science, leveraging deep domain expertise to support technical founding teams.
What's next for Bexorg?
With this major strategic investment, Bexorg is poised to accelerate its mission in CNS drug discovery and development. The substantial capital infusion, totaling $23M, indicates a Series A or later stage of growth, suggesting the company is scaling its operations and further developing its AI-driven neuroscience platform. Future endeavors will likely focus on expanding clinical validation, enhancing the predictive capabilities of its BrainEx platform, and forging strategic partnerships within the pharmaceutical and biotechnology industries. The company's commitment to rigorous scientific standards and ethical practices positions it for sustained advancement in a critical area of medical research.
See full Bexorg company page
